As of today, the number of lives taken due to cervical cancer is decreased with more women appreciating the benefits of early detection through regular and annual pap smears. Because more women are now more careful of their body and their health, cervical cancer is now deduced from being a killer disease to an illness that is easily prevented and detected.

Cancer of the cervix has 4 stages - stages 1 to 4. In this case, stage 1 is the earliest (and less dangerous) and stage 4 is the most dangerous.

Stage 1 has two phases: Stage 1A and Stage 1B. At the 1st phase, the Cervical Cancer Survival Rate is pretty agreeable at 96-99%. Since this is the first phase of your cancer experience, the cancer is still localized and may be easily taken by surgery. Stage 1B has around 80-90% rate of survival and may be treated with a combination of surgery, chemo and radiation therapy.

At stage 2, the cancer has already proliferated to the surrounding tissues outside the uterus. At a five-year time period, the Cervical Cancer Survival Rate of patients diagnosed during this stage is significantly lower at 65-69%. Treatment is the same with the previous stage but dosage and frequency of the medications and therapy sessions may be higher.

In most cancer cases, it is dangerous to leave the cancer untreated until it reaches the 3rd stage. It is because prognosis at this stage is very poor and the Cervical Cancer Survival Rate is quite low at 40-43% even with adequate chemo and radiation therapy.

At the fourth stage of the disease, the cancer may have already affected the distant organs such as the pelvis and even the intestines. Even with treatment, the percentage of survival is still at 15-20%.

Cancer of the cervix is equally prevalent among women with kids and without and also to women with active sex life or those without. Like most cancers, the direct and exact cause of cancer of the cervix is unknown but is loosely related to a woman's lifestyle, race and even her socio-economic status.

The preventative and detective measures primarily suggested by most medical practitioners are biannual or annual pap smear tests as soon as a woman begins engaging in active sex or as early as eighteen years of age.

By Mert Ozge

Endometrial carcinoma or Uterine Cancer is the most common malignancy of the female population. Each year, there are about 40,300 new cases diagnosed with this type of cancer, although in many occasions (around 75%), the diagnosis is established when the tumor is confined to the body of the uterus, therefore, many tumors can be cured. The 7,000 annual deaths caused by the cancer mean that this tumor ranks as the seventh leading cause of cancer death in women. It is primarily a neoplasm of postmenopausal women, although there are 25% of cases occurring in women under 50 years and 5% in women under 40 years. It is a predominantly common in Eastern Europe and the U.S. but quite rare in Asia.

Phenotypic traits and risk factors common in patients with endometrial cancer are obesity, menstrual disorders, a low fertility rate, late menopause, lack of ovulation and bleeding after menopausal. The risk is doubled in women taking tamoxifen to treat or prevent breast cancer. The maximum age of onset of endometrial carcinoma is the sixth and seventh decades of life. The symptoms are: abnormal vaginal discharge (90%), abnormal bleeding (80%), usually postmenopausal and vaginal discharge (10%). The study of patients with endometrial cancer may require a history and physical and gynecological examination, followed by endometrial biopsy or dilation of the cervix with fractional curettage. It may require an invasive procedure or minor surgery to establish the extent and degree of myometrial invasion or determine the staging. You have to take samples of peritoneal fluid, to explore the abdomen and pelvis, and perform a pelvic lymphadenectomy. As of today, around 74% of the patients are in stage I, 13% in stage II, 9% stage III, and 3% stage IV.

Uterine Cancer Survival rates at five years are as follows: Stage I: 89%, stage II: 80%, stage III: 30%, and stage IV: 9%.

A superficial invasion of the uterus (Stage I) can be treated with chemotherapy, but if the invasion is a bit larger, your doctor may suggest a radical hysterectomy or preoperative radiotherapy followed by extrafascial hysterectomy. About 15% of women with endometrial cancer are in stage II and the treatment depends on the intensity of this invasion. When the process has spread outside the uterus, but remains within the pelvis (stage III), treatment usually consists of surgery plus radiation. Patients whose cancer is only confined in the ovary and fallopian tubes, outcome with this treatment is quite high (80% uterine cancer survival rate at five years). Other stage III patients with a tumor spread beyond the Annexes and those with serous endometrial carcinoma have a significantly worse prognosis (uterine cancer survival rate of 15% at five years).

By Mert Ozge

A brain cancer survival rate refers to the percentage of people who were reported still living after being diagnosed with the cancer about 5 yrs ago.

Basically, brain tumor is the abnormal growth of cells in the brain and we commonly refer to it as cancer cells. There are different ways in which a tumor may spread. One is that it can be a cause of the spread of cancerous cells originating from another body part or the cancer cells are really coming from the brain itself.

It is true that exposure to harmful chemicals leads to abnormal growth of brain tumor. It was statistically confirmed that about 80% of brain cancer patients are suffering from oligodendroglioma.

Cancer of the brain remains one of the most incurable cancers with an average survival period of one to two years.

Factors Affecting Survival

A five-year brain cancer survival rate may be influenced by several factors including the size of the tumor, at which part of the brain, the severity of the cancer and the stage. In most occasions, the general health of the patient is also an indicative factor of survival.

How do you calculate the rate of survival?

Survival statistics are based on a large number of people, and should not be used to predict the survival of an individual or patient.

Healthline.com reported that children at the age of 14 have around 73 percent chance of surviving cancer of the brain and live until five years of more, while the rate drops to 55 percent with young adults between 15 and 44. Middle-aged patients between 45 and 64 have a rate of 16 percent, and older people have a survival rate of only 5 percent.

Other facts

Statistical facts show that with the proper combination and usage of radiotherapy and chemotherapeutic drugs, the lives of those with brain cancer may be prolonged. In some patients, the quality of live may even be improved but there are those who easily give up and were not luckily able to live more than 2 years.

The brain cancer survival rate presented here is based on a relative result. The total 5-year brain cancer survival rate from the years 1995-2001 was more than 33%. The relative survival rates at 5 years for brain cancer by race and sex were:

• 32.1 percent of Caucasian men
• 37.7 percent for African-American men
• 33.5 percent of Caucasian women
• 37.5 percent for African-American women.

Brain cancer survival rate statistics reveals that about 85% of physical disorders were affected by the negative mental and emotional stress at the fourth/metastatic stage of the disease.

Many patients could attest to the fact that negative emotion and mental stress weaken the immune system despite the fact that there is no such direct connection between negative emotion and cancer, medically speaking. This is one thing we should remember when dealing with patients suffering from cancer, in general.